colonoscopy or other visualization techniques, and FOBT should therefore be accurate and sensitive enough to achieve a high analytic and diagnostic accuracy for cancers and precancerous colorectal neoplasia. In our opinion the guaiac-based tests, even socalled 'reference' or 'sensitive' tests, do not meet these requirements: they are problematic considering the preanalytical, analytical, and postanalytical points of view (especially the interpretation of spurious colour) and the high false-positive and false-negative rates. The only screening that may reach the necessary diagnostic sensitivity and speci¢city with clinically relevant positive and negative predictive values is immunochemical testing without any special dietary adjustment or specimen preparation, including delay of testing. Such screening is, in our opinion, more cost-e¡ective than guaiac testing or a combined guaiac and immunochemical approach because it cuts down on unnecessary and expensive retesting and follow-up procedures.
We thank Drs Anthony and Skitek for responding to our Short Report, which recommends that green colours found with guaiac-based faecal occult blood tests (FOBT) should be reported as positive. 1 We are pleased that Immunostics Inc., the manufacturer of Hema-screen, the FOBT used in the ¢rst 2 and second colorectal cancer screening rounds in both Scotland and England, agrees with out ¢ndings. It is particularly gratifying to note that the instruction sheet for this product now includes our ¢ndings and recommendations.
Dr Skitek's data with another widely used guaiacbased FOBT support our ¢nding that green colours should be regarded as positive. Some important additional points on FOBT are also raised. We do not advocate dietary restriction for guaiac FOBT: there is a published meta-analysis which supports our view that this is unnecessary. 3 Dr Skitek states that the only possible screening approach is the use of a single immunochemical FOBT and that this is cost-e¡ective. This is opinion, however, and we refer readers to two excellent recent articles that objectively debate the advantages and disadvantages of guaiac and immunochemical FOBT and the various approaches possible for screening. 4, 5 Clearly, there is no single correct approach and the strategy adopted must be decided on a countryby-country basis, taking many factors into consideration. 4 In addition, it should be emphasized that the role of immunochemical FOBT in a population screening context has not been tested in a randomized setting.
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